D-Index & Metrics Best Publications
Karin Haustermans

Karin Haustermans

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 78 Citations 26,072 559 World Ranking 12732 National Ranking 149

Overview

What is she best known for?

The fields of study Karin Haustermans is best known for:

  • Cancer
  • Chemotherapy
  • Radiation therapy

Her study in Pathological extends to Internal medicine with its themes. Karin Haustermans undertakes interdisciplinary study in the fields of Cancer and Breast cancer through her works. Breast cancer and Cancer are two areas of study in which Karin Haustermans engages in interdisciplinary work. She undertakes interdisciplinary study in the fields of Radiation therapy and Chemoradiotherapy through her research. She merges Chemoradiotherapy with Radiation therapy in her study. Colorectal cancer and Total mesorectal excision are two areas of study in which Karin Haustermans engages in interdisciplinary work. Borrowing concepts from Colorectal cancer, Karin Haustermans weaves in ideas under Total mesorectal excision. Karin Haustermans conducted interdisciplinary study in her works that combined Radiology and Nuclear medicine. In her papers, Karin Haustermans integrates diverse fields, such as Nuclear medicine and Positron emission tomography.

Her most cited work include:

  • Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data (1385 citations)
  • Gastric cancer (1297 citations)
  • Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) (1082 citations)

What are the main themes of her work throughout her whole career to date

Her research combines Randomized controlled trial and Internal medicine. In her research, she performs multidisciplinary study on Cancer and Cancer research. She undertakes multidisciplinary studies into Cancer research and Cancer in her work. She integrates Oncology and Surgery in her studies. In her papers, Karin Haustermans integrates diverse fields, such as Surgery and Internal medicine. She incorporates Nuclear medicine and Radiation therapy in her research. She integrates several fields in her works, including Radiology and Magnetic resonance imaging. As part of her studies on Prostate cancer, she frequently links adjacent subjects like Prostatectomy. In her research, she performs multidisciplinary study on Colorectal cancer and Chemoradiotherapy.

Karin Haustermans most often published in these fields:

  • Internal medicine (87.33%)
  • Cancer (78.73%)
  • Radiation therapy (55.20%)

What were the highlights of her more recent work (between 2019-2022)?

  • Internal medicine (96.77%)
  • Cancer (90.32%)
  • Oncology (58.06%)

In recent works Karin Haustermans was focusing on the following fields of study:

Prostatectomy and External beam radiotherapy are the subject areas of her Prostate cancer study. Karin Haustermans regularly ties together related areas like Urinary system in her Internal medicine studies. Karin Haustermans integrates many fields, such as Cancer and Lymph node, in her works. She performs multidisciplinary study in the fields of Oncology and Urology via her papers. She brings together Urology and Oncology to produce work in her papers. Her Randomized controlled trial research extends to the thematically linked field of Surgery. Many of her studies on Randomized controlled trial apply to Surgery as well. Karin Haustermans merges Radiology with Magnetic resonance imaging in her research. She integrates Nuclear medicine with Radiation therapy in her study.

Between 2019 and 2022, her most popular works were:

  • Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial (185 citations)
  • Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer (73 citations)
  • International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer (56 citations)

In her most recent research, the most cited works focused on:

  • Cancer
  • Clinical trial
  • Chemotherapy

Karin Haustermans is researching Radiation therapy as part of the investigation of Chemoradiotherapy, External beam radiotherapy and Radiation oncology. Karin Haustermans brings together Chemoradiotherapy and Colorectal cancer to produce work in her papers. Karin Haustermans brings together Colorectal cancer and Total mesorectal excision to produce work in her papers. Phases of clinical research and Acute toxicity are inherently bound to her Toxicity studies. Her work blends Acute toxicity and Toxicity studies together. Law is intertwined with Standardization and MEDLINE in her research. The study of MEDLINE is intertwined with the study of Law in a number of ways. She regularly links together related areas like Endpoint Determination in her Internal medicine studies. Her research is interdisciplinary, bridging the disciplines of Systemic therapy and Cancer.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

E. Van Cutsem;A. Cervantes;R. Adam;A. Sobrero.
Annals of Oncology (2016)

2583 Citations

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

Monique Maas;Patty J. Nelemans;Vincenzo Valentini;Prajnan Das.
Lancet Oncology (2010)

1646 Citations

Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)

Michel Bolla;Hendrik Van Poppel;Laurence Collette;Paul van Cangh.
The Lancet (2005)

1636 Citations

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

H J Schmoll;E Van Cutsem;A Stein;V Valentini.
Annals of Oncology (2012)

1622 Citations

Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

M. Ducreux;M. Ducreux;A. Sa. Cuhna;C. Caramella;A. Hollebecque.
Annals of Oncology (2015)

1023 Citations

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

Michel Bolla;Hein van Poppel;Bertrand Tombal;Kris Vekemans.
The Lancet (2012)

803 Citations

Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

F. Lordick;C. Mariette;K. Haustermans;Radka Obermannová.
Annals of Oncology (2013)

735 Citations

Utility of Positron Emission Tomography for the Staging of Patients With Potentially Operable Esophageal Carcinoma

P Flamen;A Lerut;E Van Cutsem;W De Wever.
Journal of Clinical Oncology (2000)

695 Citations

EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

Cornelis J.H. Van De Velde;Petra G. Boelens;Josep M. Borras;Jan Willem Coebergh.
European Journal of Cancer (2014)

476 Citations

Multidisciplinary Rectal Cancer Management : 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

Vincenzo Valentini;Cynthia Aristei;Bengt Glimelius;Bruce D. Minsky.
Radiotherapy and Oncology (2009)

392 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Karin Haustermans

Regina G. H. Beets-Tan

Regina G. H. Beets-Tan

Antoni van Leeuwenhoek Hospital

Publications: 124

Bengt Glimelius

Bengt Glimelius

Uppsala University

Publications: 88

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 83

Geerard L. Beets

Geerard L. Beets

Antoni van Leeuwenhoek Hospital

Publications: 82

Philippe Lambin

Philippe Lambin

Maastricht University

Publications: 70

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 65

Steven Joniau

Steven Joniau

KU Leuven

Publications: 55

Jaffer A. Ajani

Jaffer A. Ajani

The University of Texas MD Anderson Cancer Center

Publications: 49

Florian Lordick

Florian Lordick

Leipzig University

Publications: 47

David Cunningham

David Cunningham

Royal Marsden NHS Foundation Trust

Publications: 47

Volker Heinemann

Volker Heinemann

Ludwig-Maximilians-Universität München

Publications: 46

Eric Van Cutsem

Eric Van Cutsem

KU Leuven

Publications: 46

Claus Rödel

Claus Rödel

Goethe University Frankfurt

Publications: 46

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 45

Alfredo Falcone

Alfredo Falcone

University of Pisa

Publications: 41

Andrés Cervantes

Andrés Cervantes

University of Valencia

Publications: 41

Trending Scientists

Oscar Pizarro

Oscar Pizarro

University of Sydney

Olivier F. X. Donard

Olivier F. X. Donard

University of Pau and the Adour Region

Jean Galy

Jean Galy

University of Bordeaux

Aleksandr Noy

Aleksandr Noy

Lawrence Livermore National Laboratory

Hiroki Ago

Hiroki Ago

Kyushu University

Kristen E. Lukas

Kristen E. Lukas

Cleveland Metroparks Zoo

Patrick Maurel

Patrick Maurel

University of Montpellier

Petri Lehenkari

Petri Lehenkari

Oulu University Hospital

Suzanne Mahlburg Kay

Suzanne Mahlburg Kay

Cornell University

Bernhard Holzmann

Bernhard Holzmann

Technical University of Munich

Deborah M. Capaldi

Deborah M. Capaldi

University of Oregon

Stephen W. Hwang

Stephen W. Hwang

University of Toronto

Elizabeth Selvin

Elizabeth Selvin

Johns Hopkins University

Ayumi Shintani

Ayumi Shintani

Vanderbilt University

Kenneth W. Muir

Kenneth W. Muir

University of Manchester

Henri Lefebvre

Henri Lefebvre

Université Paris Cité

Something went wrong. Please try again later.